DaVita HealthCare Partners Inc (DVA)vsGuardian Pharmacy Services, Inc. (GRDN)
DVA
DaVita HealthCare Partners Inc
$155.11
+1.19%
HEALTHCARE · Cap: $10.25B
GRDN
Guardian Pharmacy Services, Inc.
$37.57
+0.83%
HEALTHCARE · Cap: $2.42B
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 842% more annual revenue ($13.64B vs $1.45B). DVA leads profitability with a 5.5% profit margin vs 3.4%. DVA trades at a lower P/E of 16.1x. DVA earns a higher WallStSmart Score of 66/100 (B-).
DVA
Strong Buy66
out of 100
Grade: B-
GRDN
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.7%
Fair Value
$163.40
Current Price
$155.11
$8.29 discount
Margin of Safety
-552.6%
Fair Value
$5.30
Current Price
$37.57
$32.27 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 65 in profit
Growing faster than its price suggests
Attractively priced relative to earnings
Safe zone — low bankruptcy risk
Every $100 of equity generates 27 in profit
17.4% revenue growth
Areas to Watch
5.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
Trading at 11.6x book value
0.0% earnings growth
3.4% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bull Case : GRDN
The strongest argument for GRDN centers on Altman Z-Score, Return on Equity, Revenue Growth. Revenue growth of 17.4% demonstrates continued momentum.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : GRDN
The primary concerns for GRDN are Price/Book, EPS Growth, Profit Margin. A P/E of 48.2x leaves little room for execution misses. Thin 3.4% margins leave little buffer for downturns.
Key Dynamics to Monitor
DVA profiles as a value stock while GRDN is a growth play — different risk/reward profiles.
GRDN is growing revenue faster at 17.4% — sustainability is the question.
DVA generates stronger free cash flow (395M), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DVA scores higher overall (66/100 vs 46/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Guardian Pharmacy Services, Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Guardian Pharmacy Services, Inc. is a leading provider of specialized pharmacy solutions for the long-term care sector, which includes assisted living and skilled nursing facilities. The company is distinguished by its commitment to personalized medication management, ensuring high standards of quality and compliance while delivering exceptional customer service. Leveraging advanced technology and deep pharmaceutical expertise, Guardian aims to enhance patient outcomes and streamline workflows for its healthcare partners. With a strong operational presence across multiple states, the company is well-positioned to address the growing needs for tailored pharmacy services amidst an evolving healthcare landscape.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?